GlassScriptPhysician profile
Samuel Wayne Steury
NPI 1396907952
$2,913.11
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,243 · 2020: $218 · 2021: $69.26 · 2022: $13.33 · 2023: $312 · 2024: $57.60.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $340 · Education: $30.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $339.62 |
| Education | $30.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $1,768.34 | 2019 | |
| Boston Scientific Corporation | $706.94 | 2019-2024 | Therasphere Administration Set, Embold Fibered, Therasphere Y90 Glass Microspheres 10 Gbq |
| Cardiovascular Systems INC. | $116.02 | 2020 | |
| Medtronic Vascular, INC. | $109.95 | 2019-2020 | |
| Medtronic, INC. | $47.56 | 2022-2023 | Pipeline |
| Cardiva Medical, INC. | $26.26 | 2023 | Cardiva Vascade 6/7f Vcs |
| Depuy Synthes Sales INC. | $26.25 | 2019 | |
| Becton, Dickinson and Company | $22.49 | 2024 | Lutonix Drug Coated Balloon |
| Varian Medical Systems, INC. | $20.00 | 2021 | |
| Sirtex Medical INC | $19.33 | 2023 | Sir-Spheres Microspheres |
| Angiodynamics, INC. | $19.03 | 2020 | |
| Genentech USA, INC. | $15.73 | 2019 | |
| Terumo Medical Corporation | $15.21 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Steury listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.